Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.

Antimicrobial agents and chemotherapy - 1 Sept 2010

Cai Yun, Li Ran, Liang Beibei, Bai Nan, Liu Youning, Wang Rui

Abstract excerpt

The antimicrobial activities of colistin and other antibiotics against clinical Acinetobacter baumannii and the mutant prevention concentration (MPC) of colistin against multidrug-resistant A. baumannii were studied. All 70 stains tested were sensitive to colistin. The MPC range of colistin against 30 multidrug-resistant A. baumannii stains was approximately 32 to >128 microg/ml, and the MPC at which 90% of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Anti-Bacterial Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibiotic Resistance in Bacteria

Share to Antibiotics Pharmacokinetics and Efficacy

Share to Colistin

Share to Drug Resistance, Multiple, Bacterial

Share to Microbial Sensitivity Tests

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 20585134
DOI: 10.1128/AAC.00264-10
PMCID: PMC2934956

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.PMID 20585134Read ↗

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolatesSemantic proximity Read ↗

Treatment of Colistin Dependence-Developing Acinetobacter baumannii with Antibiotic Combinations at Subinhibitory Concentrations.Semantic proximity Read ↗

Mutant prevention concentrations of four carbapenems against gram-negative rods.Semantic proximity Read ↗

Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii.Semantic proximity Read ↗

Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolatesSemantic proximity Read ↗

Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.Semantic proximity Read ↗

Promoters of Colistin Resistance in Acinetobacter baumannii InfectionsSemantic proximity Read ↗

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii.Semantic proximity Read ↗

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.Semantic proximity Read ↗

Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii.Semantic proximity Read ↗

Therapeutic options in an era of decreasing antimicrobial susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.